Global Radiopharmaceutical Market Outlook to 2024: Analysis by Product (Diagnostics & Therapeutics) and Region (North America, Europe, Asia Pacific) - ResearchAndMarkets.com

August 7, 2018

DUBLIN--(BUSINESS WIRE)--Aug 7, 2018--The “Global Radiopharmaceutical Market (By Products - Diagnostics & Therapeutics; By Region - North America-The US; Europe-The UK & Germany; and Asia Pacific-Japan & China) Outlook 2024” report has been added to ResearchAndMarkets.com’s offering.

Growth dynamics of the healthcare industry overall moves in conjugation with that of radiopharmaceuticals due to its widespread application in various healthcare domains such as cardiology, oncology, neurology, etc.

Market demand for radiopharmaceuticals has been consistently progressing due to higher incidences of chronic diseases, the prevalence of cancer and other cardiac ailments and increasing awareness of radiopharmaceuticals. However, some of the factors restraining the growth of the industry are stringent regulatory norms, scarcity of radioisotopes and the high cost of procedure.

The report provides information on the current scenario, detailed market outlook of the global radiopharmaceutical market with detailed analysis of market segments such as Diagnostics & Therapeutics.

The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Future forecasts of radiopharmaceutical market overall and across various sub-segments has been provided till 2024, for all the geographies.

Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the market includes Siemens Healthineers AG, GE Healthcare, IBA RadioPharma Solutions, Lantheus Holdings, Inc. and Eckert & Ziegler. These players are profiled herein based on attributes such as business overview, product segments and financial analysis.

It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section.

In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional radiopharmaceutical market.

Key Topics Covered

1. Executive Summary

2. Research Methodology

3. Radiopharmaceutical

4. Market Analysis

5. Market Segmentation

6. Regional Analysis

7. Market Dynamics

8. Competitive Landscape

9. Company Profiles

Eckert & Ziegler GE Healthcare IBA RadioPharma Solutions Lantheus Holdings Inc. Siemens Healthineers AG

For more information about this report visit https://www.researchandmarkets.com/research/7384h2/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180807005731/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics,Nuclear Medicine and Radiopharmacology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/07/2018 01:39 PM/DISC: 08/07/2018 01:39 PM


Update hourly